Momidi Bharath Kumar

Momidi Bharath Kumar

Auto-generated profile, based on publicly available information

Momidi Bharath Kumar

Sri Venkateswara Arts College

Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 December 2024 in Organic Communications
Verified
Journal Article
Closed access
VNVipin A Nair
Vipin A Nair
AMAiyagala M.M. Mallikarjunasawamy
Aiyagala M.M. Mallikarjunasawamy
PNPraveen Naik
Praveen Naik
MKMomidi Bharath Kumar
Momidi Bharath Kumar
KGKuruvalli Gouthami
Kuruvalli Gouthami
DVDamodara Reddy Vaddi
Damodara Reddy Vaddi
The infectious diseases caused by antimicrobial pathogens are often difficult to treat and thwarted by resistance to drugs. Therefore, designing new drugs to treat antimicrobial infections is a challenge in drug discovery research. A series of 2-thioxoimidazolidinone derivatives were synthesized in high yield from N'-arylideneamino-2-thioxoimidazolidin-4-ones using propionyl chloride and triethyl amine in toluene medium. The compounds were screened for the in vitro antifungal and antibacterial activities. The studies revealed that compounds (±)1,1'-(3-(((1E,2E)-3-(2-methoxyphenyl)allylidene)amino)-4-oxo-2-thioxoimidazolidine-1,5-diyl)-bis(propan-1-one) and (±)1,1'-(3-((2,4-dichlorobenzylidene)amino)-4-oxo-2-thioxoimidazolidine-1,5-diyl)bis-(propan-1-one) possess antifungal properties comparable to the reference drug ketoconazole. This study highlights the importance of substituted 2-thioxoimidazolidinone derivatives, and their potential as antimicrobial agents.